Clinical aspects of beta-blockade.
beta-Blocking drugs have no or only a partial beta-agonistic activity (ISA). Since they all bind to beta receptors, they act as competitive inhibitors of the endogenous catecholamines. In addition to this common effect, the beta-blocking drugs also have other properties that may be clinically important, such as extent of beta 1 selectivity, ISA, and lipophilicity. The importance of these properties in the clinical setting is reviewed.